0001708138-20-000052.txt : 20200508 0001708138-20-000052.hdr.sgml : 20200508 20200508160413 ACCESSION NUMBER: 0001708138-20-000052 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200506 FILED AS OF DATE: 20200508 DATE AS OF CHANGE: 20200508 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Van Plew Daniel P CENTRAL INDEX KEY: 0001411984 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19034 FILM NUMBER: 20860495 MAIL ADDRESS: STREET 1: REGENERON PHARMACEUTICALS, INC. STREET 2: 777 OLD SAW MILL RIVER ROAD CITY: TARRYTOWN STATE: NY ZIP: 10591 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: REGENERON PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0000872589 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 133444607 STATE OF INCORPORATION: NY FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 777 OLD SAW MILL RIVER ROAD CITY: TARRYTOWN STATE: NY ZIP: 10591 BUSINESS PHONE: 9148477000 MAIL ADDRESS: STREET 1: 777 OLD SAW MILL RIVER ROAD CITY: TARRYTOWN STATE: NY ZIP: 10591 FORMER COMPANY: FORMER CONFORMED NAME: REGENERON PHARMACEUTICALS INC DATE OF NAME CHANGE: 19930328 4 1 edgardoc.xml PRIMARY DOCUMENT X0306 4 2020-05-06 0 0000872589 REGENERON PHARMACEUTICALS, INC. REGN 0001411984 Van Plew Daniel P 777 OLD SAW MILL RIVER ROAD TARRYTOWN NY 10591 0 1 0 0 EVP & General Mgr Industrial O Common Stock 2020-05-06 4 M 0 33079 52.03 A 61330 D Common Stock 2020-05-06 4 F 0 17779 555.77 D 43551 D Common Stock 2020-05-06 4 M 0 52500 52.03 A 96051 D Common Stock 2020-05-06 4 F 0 28217 555.77 D 67834 D Common Stock 2020-05-07 4 S 0 100 556.92 D 67734 D Common Stock 2020-05-07 4 S 0 600 557.59 D 67134 D Common Stock 2020-05-07 4 S 0 2118 558.43 D 65016 D Common Stock 2020-05-07 4 S 0 500 559.2 D 64516 D Common Stock 2020-05-07 4 S 0 3231 560.53 D 61285 D Common Stock 2020-05-07 4 S 0 4988 561.55 D 56297 D Common Stock 2020-05-07 4 S 0 2077 562.45 D 54220 D Common Stock 2020-05-07 4 S 0 2195 563.58 D 52025 D Common Stock 2020-05-07 4 S 0 3000 564.54 D 49025 D Common Stock 2020-05-07 4 S 0 5984 565.49 D 43041 D Common Stock 2020-05-07 4 S 0 7297 566.47 D 35744 D Common Stock 2020-05-07 4 S 0 3753 567.35 D 31991 D Common Stock 2020-05-07 4 S 0 3040 568.57 D 28951 D Common Stock 2020-05-07 4 S 0 700 569.42 D 28251 D Common Stock 1561 I By 401(k) Plan Non-Qualified Stock Option (right to buy) 52.03 2020-05-06 4 M 0 33079 0.0 D 2021-12-16 Common Stock 33079 52500 D Non-Qualified Stock Option (right to buy) 52.03 2020-05-06 4 M 0 52500 0.0 D 2021-12-16 Common Stock 52500 0 D Represents volume-weighted average price of sales of 600 shares of Company stock on May 7, 2020 at prices ranging from $557.13 to $557.89. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 7, 2020 at each separate price. Represents volume-weighted average price of sales of 2,118 shares of Company stock on May 7, 2020 at prices ranging from $558.02 to $558.80. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 7, 2020 at each separate price. Represents volume-weighted average price of sales of 500 shares of Company stock on May 7, 2020 at prices ranging from $559.05 to $559.36. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 7, 2020 at each separate price. Represents volume-weighted average price of sales of 3,231 shares of Company stock on May 7, 2020 at prices ranging from $560.00 to $560.93. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 7, 2020 at each separate price. Represents volume-weighted average price of sales of 4,988 shares of Company stock on May 7, 2020 at prices ranging from $561.00 to $561.97. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 7, 2020 at each separate price. Represents volume-weighted average price of sales of 2,077 shares of Company stock on May 7, 2020 at prices ranging from $562.03 to $562.94. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 7, 2020 at each separate price. Represents volume-weighted average price of sales of 2,195 shares of Company stock on May 7, 2020 at prices ranging from $563.00 to $563.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 7, 2020 at each separate price. Represents volume-weighted average price of sales of 3,000 shares of Company stock on May 7, 2020 at prices ranging from $564.04 to $564.92. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 7, 2020 at each separate price. Represents volume-weighted average price of sales of 5,984 shares of Company stock on May 7, 2020 at prices ranging from $565.03 to $565.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 7, 2020 at each separate price. Represents volume-weighted average price of sales of 7,297 shares of Company stock on May 7, 2020 at prices ranging from $566.00 to $566.95. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 7, 2020 at each separate price. Represents volume-weighted average price of sales of 3,753 shares of Company stock on May 7, 2020 at prices ranging from $567.00 to $567.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 7, 2020 at each separate price. Represents volume-weighted average price of sales of 3,040 shares of Company stock on May 7, 2020 at prices ranging from $568.10 to $568.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 7, 2020 at each separate price. Represents volume-weighted average price of sales of 700 shares of Company stock on May 7, 2020 at prices ranging from $569.02 to $569.76. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 7, 2020 at each separate price. With respect to 33,079 underlying shares (of which 0 remain outstanding), the stock option award vested in four equal annual installments, commencing one year after the date of grant. With respect to 52,500 underlying shares (of which 0 remain outstanding), the option became exercisable on December 31, 2014, based upon the satisfaction by the company of certain performance criteria during the period ended December 31, 2014. /s/**Daniel P. Van Plew 2020-05-08